FORMULATION AND IN VITRO EVALUATION OF SELF NANO EMULSIFYING DRUG DELIVERY SYSTEM OF QUERCETIN FOR ENHANCEMENT OF ORAL BIOAVAILABILITY

ROMA MATHEW; JOYAMMA VARKEY

doi:10.22159/ijcpr.2022v14i1.44113

Authors

ROMA MATHEW Government Medical College, Thiruvananthapuram, Kerala 695011
JOYAMMA VARKEY Government Medical College, Thiruvananthapuram, Kerala 695011

DOI:

https://doi.org/10.22159/ijcpr.2022v14i1.44113

Keywords:

Self nanoemulsifying drug delivery system, Quercetin, In vitro evaluation, Oral bioavailability

Abstract

Objective: The study aims to develop a Self-nanoemulsifying drug delivery system (SNEDDS) of Quercetin to enhance its oral bioavailability.

Methods: In the present study, Quercetin was formulated into SNEDDS using various oils, surfactants, and co-surfactants. The developed formulations were subjected to various studies like drug content analysis, droplet size and thermodynamic stability, and in vitro drug release studies.

Results: From the screening of oils, surfactant and cosurfactant, the combination of Triacetin as oil phase, Tween 20 as surfactant and Ethanol as co-surfactant was selected for the development of SNEDDS of Quercetin. The composition of the formulation was optimized using pseudo ternary phase diagram. The optimized formulation has been evaluated and found to have good physical stability and improved in vitro drug release.

Conclusion: A stable SNEDDS of Quercetin was developed, and results indicated substantial enhancement in the dissolution of the drug when formulated as a self-nano emulsifying drug delivery system, indicating its potential to enhance oral solubility and bioavailability of the drug.

Downloads

Download data is not yet available.

References

Formica JV, Regelson W. Review of the biology of quercetin and related bioflavonoids. Food Chem Toxicol. 1995;33(12):1061-80. doi: 10.1016/0278-6915(95)00077-1, PMID 8847003.

Thilakarathna SH, Rupasinghe HP. Flavonoid bioavailability and attempts for bioavailability enhancement. Nutrients. 2013;5(9):3367-87. doi: 10.3390/nu5093367, PMID 23989753.

Cai X, Fang Z, Dou J, Yu A, Zhai G. Bioavailability of quercetin: problems and promises. Curr Med Chem. 2013;20(20):2572-82. doi: 10.2174/09298673113209990120, PMID 23514412.

Jain S, Jain AK, Pohekar M, Thanki K. Novel self-emulsifying formulation of quercetin for improved in vivo antioxidant potential: implications for drug-induced cardiotoxicity and nephrotoxicity. Free Radical Biol Med. 2013;65:117-30. doi: 10.1016/j.freeradbiomed.2013.05.041, PMID 23792276.

Zhao J, Yang J, Xie Y. Improvement strategies for the oral bioavailability of poorly water-soluble flavonoids: an overview. Int J Pharm. 2019;570:118642. doi: 10.1016/ j.ijpharm.2019.118642, PMID 31446024.

Rani S, Rana R, Saraogi GK, Kumar V, Gupta U. Self-emulsifying oral lipid drug delivery systems: advances and challenges. AAPS PharmSciTech. 2019;20(3):1-2. A Pandey, Rath B, AK D. Pharmaceutical preformulation studies with special emphasis on excipients compatibility. Chem Inform. 2012;43(23):20-5.

Savale SK. A review-self nano emulsifying drug delivery system (SNEDDS). Int J Res Pharm Nano Sci. 2015;4(6):385-97.

Mathew R, Varkey J. Development of a validated RP-HPLC method for estimation of quercetin. Asian J Pharm Health Sci. 2021;11(1):2415-22. doi: 10.5530/ajphs.2021.11.1.

Sharma G, Wilson K, Van der Walle CF, Sattar N, Petrie JR, Ravi Kumar MN. Microemulsions for oral delivery of insulin: design, development and evaluation in streptozotocin-induced diabetic rats. Eur J Pharm Biopharm. 2010;76(2):159-69. doi: 10.1016/j.ejpb.2010.07.002, PMID 20655382.

Chaudhary S, Aqil M, Sultana Y, Kalam MA. Self-nano emulsifying drug delivery system of nabumetone improved its oral bioavailability and anti-inflammatory effects in rat model. J Drug Deliv Sci Technol. 2019 Jun 1;51:736-45. doi: 10.1016/j.jddst.2018.04.009.

Ke Z, Hou X, Jia XB. Design and optimization of self-nano emulsifying drug delivery systems for improved bioavailability of cyclovirobuxine D. Drug design, development and therapy. 2016;10:2049.

Baloch J, Sohail MF, Sarwar HS, Kiani MH, Khan GM, Jahan S, Rafay M, Chaudhry MT, Yasinzai M, Shahnaz G. Self-nano emulsifying drug delivery system (SNEDDS) for improved oral bioavailability of chlorpromazine: in vitro and in vivo evaluation. Medicina (Kaunas). 2019;55(5):210. doi: 10.3390/medicina55050210, PMID 31137751.

Pratiwi L, Fudholi A, Martien R, Pramono S. Self-nano emulsifying drug delivery system (Snedds) for topical delivery of mangosteen peels (Garcinia mangostana L.,): formulation design and in vitro studies. J Young Pharm. 2017;9(3):341-6. doi: 10.5530/jyp.2017.9.68.

Ali HH, Hussein AA. Oral solid self-nanoemulsifying drug delivery systems of candesartan citexetil: formulation, characterization and in vitro drug release studies. AAPS Open. 2017;3(1):1-7.

Bhagwat DA, Swami PA, Nadaf SJ, Choudhari PB, Kumbar VM, More HN, Killedar SG, Kawtikwar PS. Capsaicin loaded solid SNEDDS for enhanced bioavailability and anticancer activity: in vitro, in silico, and in vivo Characterization. J Pharm Sci. 2021;110(1):280-91. doi: 10.1016/j.xphs.2020.10.020, PMID 33069713.

Gupta S, Chavhan S, Sawant KK. Self-nanoemulsifying drug delivery system for adefovir dipivoxil: design, characterization, in vitro and ex vivo evaluation. Colloids Surf A Physicochem Eng Aspects. 2011 Dec 5;392(1):145-55. doi: 10.1016/j.colsurfa.2011.09.048.

Dabhi M, Patel S, Mori D, Patel D, Patel N, Parmar R. Formulation, evaluation and optimization of self-Nano emulsifying drug delivery system containing felodipine. Micro Nanosystems. 2014 Aug 1;6(3):193-204. doi: 10.2174/187640290603150112123557.

Inugala S, Eedara BB, Sunkavalli S, Dhurke R, Kandadi P, Jukanti R, Bandari S. Solid self-nanoemulsifying drug delivery system (S-SNEDDS) of darunavir for improved dissolution and oral bioavailability: in vitro and in vivo evaluation. Eur J Pharm Sci. 2015 Jul 10;74:1-10. doi: 10.1016/j.ejps.2015.03.024, PMID 25845633.

Zhao Y, Wang C, Chow AH, Ren K, Gong T, Zhang Z, Zheng Y. Self-nanoemulsifying drug delivery system (SNEDDS) for oral delivery of zedoary essential oil: formulation and bioavailability studies. Int J Pharm. 2010 Jan 4;383(1-2):170-7. doi: 10.1016/j.ijpharm.2009.08.035, PMID 19732813.